The U.S. Food and Drug Administration (FDA) clear the drug Praxbind for emergency use to reverse the blood-thinning effects of Pradaxa. The FDA stated that the use of Praxbind to reverse the blood-thinning effects of Pradaxa puts patients at risk for blood clots and stroke, and they should resume taking Pradaxa as soon as possible. Via MedlinePlus. Posted October 16, 2015.
–Alanna McCatty
